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Edited by Shou-Wei DingAbstract While Dicer alone has been shown to form stable
complexes with double-stranded RNAs and short interfering
RNAs, its interactions with single-stranded RNAs (ssRNAs)
have not been characterized. Here, we show that recombinant
human Dicer alone can bind 21-nt ssRNAs in vitro, independent
of their sequence and structure. We also demonstrate that Dicer
binds ssRNAs having a 5 0-phosphate with greater aﬃnity versus
those with a 5 0-hydroxyl. In addition, 3 0-biotinylated ssRNAs are
bound by Dicer with lower aﬃnity than 3 0-hydroxyl ssRNAs.
The stability of ssRNA–Dicer complexes was found to depend
on divalent cations. Together, our results suggest a role for the
PAZ domain of Dicer in binding ssRNAs and may indicate roles
for Dicer in cellular function beyond those currently known.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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RNA interference (RNAi) is an evolutionarily conserved
mode of gene regulation and host defense in eukaryotes [1,2].
This mechanism of gene silencing is induced either by endo-
genously-generated precursor microRNAs (pre-miRNAs) or
exogenously-introduced double-stranded RNAs (dsRNAs).
Both pre-miRNAs and exogenous dsRNAs serve as substrates
for Dicer, a cytoplasmic RNaseIII family protein [3,4], that
cleaves them into 21 nt miRNAs and short interfering RNAs
(siRNAs), respectively. Unlike Drosophila, in which separate
Dicer proteins generate miRNAs and siRNAs [5], humans
have one Dicer enzyme that performs both functions [4].
Human Dicer is a multi-domain protein with an N-terminal
RNA helicase/ATPase domain, a domain of unknown func-
tion (DUF 283), a Piwi Argonaute Zwille (PAZ) domain,
two RNAseIII domains (RIIIa and RIIIb), and a double-
stranded RNA binding domain (dsRBD) [6,7]. The functions
of the DUF 283 domain, which has a fold similar to a dsRBD
[8], and the helicase/ATPase domain have not yet been de-
scribed. The RNase domains cleave the target dsRNA into
siRNAs and miRNAs with characteristic 2 nt overhangs at
each 3 0 end [9,10]. The C-terminal dsRBD and the PAZ do-*Corresponding author. Fax: +1 517 432 1105.
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to generate the characteristic miRNA/siRNA structure [10].
The PAZ domain is highly conserved and is found only in
Dicer and Argonaute family proteins, including Ago2, the
key catalytic component of RISC [11–14]. The PAZ domain
of Dicer plays a central role in dsRNA substrate recognition
and binding, resulting in the preference of Dicer for substrate
dsRNAs possessing 3 0 overhangs as compared to blunt end
substrates [10,15,16]. Structural studies using an isolated Dro-
sophila Ago2 PAZ domain have revealed an oligonucleotide-
binding fold that is known to bind single-stranded nucleic
acids [17–19]. Binding studies have demonstrated PAZ domain
binding to siRNAs and also 21-nt single-stranded RNAs
(ssRNAs) [19]. PAZ domains from diﬀerent human Argonaute
proteins have also been shown to bind to ssRNAs [20]. As the
Dicer PAZ domain has been suggested to bind to the single-
stranded 3 0 ends of dsRNA and the Argonaute PAZ domain
binds ssRNAs, we investigated the ability of the full-length,
puriﬁed human Dicer to bind 21-nt ssRNAs. We show that
Dicer alone can bind 21-nt ssRNAs, independent of their
sequence and predicted secondary structure.2. Materials and methods
2.1. RNA and labeling
HPLC puriﬁed RNAs were purchased from Invitrogen (Carlsbad,
CA) or Dharmacon (Lafayette, CO). Lyophilized RNAs were resus-
pended to 100 lM in TE (pH 8.0) and stored at 80 C. RNAs were
5 0-labeled with 33P-c-ATP (Perkin–Elmer Life and Analytical Sciences,
Boston, MA) using T4 polynucleotide kinase (New England Biolabs,
Ipswich, MA). Labeled strands were puriﬁed from unincorporated la-
bel using G-25 Sephadex columns (Roche Applied Science, Indianap-
olis, IN). For nonisotopic labeling, unlabeled ATP (Roche Applied
Science, Indianapolis, IN) was substituted for 33P-c-ATP. The ssRNA
and siRNA sequences used were: siRNA, 5 0-GCUGACCCUGAA-
GUUCAUCUU-3 0 (Sense strand), 5 0-GAUGAACUUCAGGGUCA-
GCUU-30 (Antisense strand); ssRNA-SS1 5 0-GUCACAUUGCCCA-
AGUCUCTT-3 0; ssRNA-SS2, 5 0-UUUUUUUUUUUUUUUUUU-
UTT-3 0. For experiments requiring 3 0-biotinylated ssRNAs, SS2 was
ordered with a 3 0-biotin. Secondary structures and melting tempera-
tures for ssRNAs were predicted using mfold [21,22].
2.2. Dicer-RNA binding assays
Recombinant human Dicer (Invitrogen) was used in all the binding
reactions. Dicer binding assays were carried out in 30 mM Tris–HCl
(pH 8.0), 250 mM NaCl, 2.5 mM MgCl2, and 0.02 mM EDTA. La-
beled ssRNA (9 nM) or siRNA (9 nM) and Dicer (200 nM, unless
otherwise speciﬁed) (Invitrogen) were incubated at 4 C for 2 h in
10 ll reaction volumes. For antibody supershift assays, either rabbit
polyclonal antibody to Dicer (Abcam, Cambridge, MA) or control
antibody to NF-jB was incubated with Dicer at 4 C for 3 h after
which labeled RNA was added and incubated for 2 additional hours.
Samples were electrophoresed at 150 V for 1.5 h at 4 C on 4–20%blished by Elsevier B.V. All rights reserved.
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to storage phosphor screens, and imaged on a Storm 860 imager (GE
Healthcare/Amersham Biosciences, Piscataway, NJ). Binding reactions
to test divalent cation dependence were carried out with the appropri-
ate divalent cation substitution for Mg2+ in the binding buﬀer. Mass
spectrometry was performed on gel-puriﬁed protein by the Michigan
State University Research Technology Support Facility.3. Results
3.1. ssRNA–Dicer complex formation in vitro
Dicer is known to form stable complexes with dsRNAs
and siRNAs [23–25], though for siRNAs some conﬂicting
reports exist [24,26]. To study whether Dicer would also
form stable complexes with ssRNAs, binding reactions were
set up with 5 0-33P ssRNAs and Dicer at 4 C (Fig. 1A). As a
control, we veriﬁed complex formation of Dicer with an
siRNA (Fig. 1A, lane 2). Two bands were seen in the case of
siRNA–Dicer binding under identical binding conditions, sug-
gesting the possible presence of ssRNA in the siRNA prepara-
tion. Faster migration of the siRNA–Dicer complex relative toFig. 1. In vitro binding of Dicer with siRNA and ssRNAs. (A) Electropho
siRNA (lane 2), structured ssRNA SS1 (lane 4), and unstructured ssRNA
complex. Curly brace indicates unbound siRNAs and ssRNAs. (B) Mass spe
showed only the presence of Dicer in the complex. (C) Electrophoretic mobil
(lane 3) and antibody against NF-jB (lane 4). The asterisk denotes the super
some RNase contamination in the binding reactions.the ssRNA–Dicer complex is due to the increase in negative
charge on the complex (due to the backbone phosphates of
the second strand) with a relatively small change in molecular
size/weight [27].
Because Dicer is naturally a dsRNA-binding protein, the
impact of secondary structure of an ssRNA on the ability of
Dicer to bind it was expected to be signiﬁcant. We tested an
ssRNA predicted to have a weak secondary structure at 4 C
(SS1) and a polyuridine ssRNA (SS2) that is presumably un-
able to form any signiﬁcant secondary structure even at 4 C.
The reduced electrophoretic motility of unbound SS2 relative
to unbound SS1 suggests the general absence of structure in
SS2 (Fig. 1A, compare lanes 3 and 5), supporting our expecta-
tions from the Tm calculations (Table 1). Both SS1 and SS2 are
bound stably by Dicer (Fig. 1A, lanes 4 and 6) as are other 21-
nt ssRNA sequences (Table 1). Identical ssRNA–Dicer com-
plexes were also formed with 12 and 15-nt ssRNAs (data not
shown).
The ssRNA–Dicer complex formed by SS1 with Dicer was
analyzed by mass spectrometry to conﬁrm the presence ofretic mobility shift assay of the complex formed between Dicer and,
SS2 (lane 6). The arrow indicates the position of the Dicer–ssRNA
ctrometry of the protein–ssRNA complex denoted by the arrow in (A)
ity shift assay of Dicer–SS2 complex in the presence of Dicer antibody
shifted complex. Bands running ahead of unbound ssRNAs may reﬂect
Table 1
Predicted DG and Tm for tested sequences
a
Name Sequence DG (kcal/mol) Tm (C)
SS1 GUC ACA UUG CCC AAG UCU CTT 0.7 20
SS2 UUU UUU UUU UUU UUU UUU UTT – –
SS3 GCU AAA AAA AAA AAA AAA ATT 1.94 19.3
SS4 GUC AAA AAA AAA AAA AAA ATT 1.94 19.3
SS5 GCU GAC CCU GAA AUU GAU CTT 0.61 32.2
SS6 GAG ACU UGG GCA AUG UGA CUT 1.62 36.7
aThough not shown due to space limitations and redundancy, binding results for sequences SS3-SS6 were similar to results for SS1 and SS2.
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conﬁrm further that the complex contained Dicer, an antibody
supershift assay was performed. Adding Dicer antibody subse-
quent to Dicer-RNA binding did not produce any shift in the
complex, so assays were performed by prior incubation of the
antibody with Dicer followed by addition of SS1. This implies
that this antibody is a competitive inhibitor of the binding by
Dicer of ssRNAs. In the presence of the Dicer antibody, the
characterized complex is nearly completely retarded as com-
pared to negative and non-speciﬁc antibody controls
(Fig. 1C, compare lane 3 with lanes 2 and 4).
3.2. Divalent cation dependence of ssRNA–Dicer complex
formation
Though Dicer requires the presence of Mg2+ to be catalyti-
cally-active [23], it has been shown to form stable complexes
with 100–130 bp dsRNAs even in the absence of Mg2+
[23,24]. Other divalent cations like Mn2+ and Co2+ can substi-
tute for Mg2+ in supporting the catalytic activity of Dicer [28].
In E. coli RNaseIII, Mg2+ and Ca2+ act to stabilize complex
formation of the enzyme with the bacteriophage T7 R1.1
RNA, which has a hairpin structure [29]. To test if ssRNA–Di-
cer complex formation depends on the presence of divalent cat-
ions, binding reactions were performed in Mg2+-free buﬀers. In
the absence of Mg2+, Dicer did not stably bind either ssRNA
(Fig. 2A, lanes 6 and 9, arrow). Complex formation was re-
stored when Mn2+ or Ca2+ were added to the buﬀer but not
Co2+, Ni2+, or Zn2+ (Fig. 2B, arrow). Similar divalent cation
dependence was not observed for the formation of a stableFig. 2. Divalent cation dependence of Dicer–ssRNA complex formation. (A)
8) and not in its absence (lanes 6 and 9). siRNA–Dicer complex formation wa
formation can occur in the presence of Mg2+, Mn2+, and Ca2+ but not Co2+siRNA–Dicer complex (Fig. 2A, lane 3). Both in the presence
and absence of divalent cations, ssRNAs appear to form smal-
ler complexes (Fig. 2B, lanes 2 and 8), but this binding could
not be assigned to a speciﬁc protein after analysis by mass
spectrometry (Fig. S1).
3.3. Possible contribution of the PAZ domain to ssRNA binding
by Dicer
Chemically synthesized siRNAs possess a 5 0-OH moiety.
Upon entry into cells, these siRNAs are immediately phos-
phorylated by the human RNA kinase hClp1 [30,31]. siRNAs
with a chemical modiﬁcation that prevents 5 0 phosphorylation
are bound by Dicer with signiﬁcantly lower aﬃnity [25]. To
assess the impact of 5 0-phosphates on complex formation be-
tween ssRNAs and Dicer, we performed a competition assay
between labeled ssRNAs in the presence of an excess of unla-
beled ssRNAs and siRNAs. At a 100-fold excess concentra-
tion, neither 5 0-OH ssRNAs nor 5 0-OH siRNAs could
displace 5 0-PO3 ssRNA SS2 from its complex with Dicer
(Fig. 3, lanes 3 and 4). However, phosphorylated strands eﬀec-
tively displaced bound SS2 (Fig. 3, lanes 5 and 6).
Of the domains in Dicer, only the PAZ domain is known to
possess a greater aﬃnity for 5 0-PO3 ssRNAs as compared to
5 0-OH ssRNAs [20]. To explore if the higher aﬃnity for 5 0-
PO3 substrates seen in ssRNA–Dicer binding was due to the
inﬂuence of the Dicer PAZ domain, binding to SS2 with a
5 0-PO3 ssRNA and a 3 0-biotin was tested. It is known that this
modiﬁcation disturbs PAZ domain-RNA interactions [20]. We
also ﬁnd that, at multiple Dicer concentrations, Dicer has aDicer–ssRNA complexes formed in the presence of Mg2+ (lanes 5 and
s not cation dependent (lanes 2 and 3). (B) Dicer–ssRNA(SS1) complex
, Ni2+, or Zn2+.
Fig. 3. Impact of 5 0-phosphate on Dicer binding aﬃnity for ssRNAs
and siRNAs. Dicer-ssRNA binding reactions were performed in the
presence of 100-fold excess unlabeled ssRNA (lanes 3 and 5) or siRNA
(lanes 4 and 6). In lanes 3 and 4, competition was performed with 5 0-
hydroxyl RNAs. In lanes 5 and 6, competition was performed with 5 0-
phosphate RNAs. The arrow indicates the position of the Dicer–
ssRNA complex.
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further suggesting a role for the PAZ domain in binding to the
ssRNAs.4. Discussion
We have shown that recombinant human Dicer alone can
bind ssRNAs in vitro and that binding is independent of the
sequence and secondary structure of the ssRNA. In all exper-
iments, the ssRNAs tested were far shorter than hairpin struc-
tures with stems of at least 29 bp in length that are known to beFig. 4. Dicer has lower aﬃnity for ssRNAs having a 3 0-biotin. (A) Representa
(lane 2) and ssRNA having a 3 0-biotin (lane 4). (B) Dependence on Dicer co
Percentage of bound RNA was calculated by normalizing intensity of s
concentration of Dicer.Dicer substrates [32]. Nonetheless, the results from our compe-
tition experiments suggest that Dicer binding of both siRNAs
and ssRNAs may occur at the same site. Though our data
strongly suggest that the PAZ domain is involved in binding,
the other characterized domains in Dicer may also participate
in the interaction.
We have demonstrated that binding of ssRNAs by Dicer de-
pends upon the presence of divalent cations. Dicer and other
RNaseIII family enzymes need one Mg2+ ion for each of the
RNase domains to be catalytically active [33]. Moreover, re-
cent structural evidence suggests that two metal ions may be
required for maximum activity [28,34]. The second metal ion
is suggested to bind to the highly negative catalytic valley of
RNaseIII enzymes and thereby stabilize the interaction be-
tween the enzyme and the negatively charged phosphate back-
bone of substrate RNA [34]. It may therefore be that the
divalent cation dependence we see for ssRNA binding is re-
lated to an interaction of the RNase domains of Dicer with
the ssRNAs. Each of these domains may simultaneously,
and possibly cooperatively, contribute to the aﬃnity of Dicer
for ssRNAs. Recent evidence for dsRNA–Dicer complex for-
mation supports this possibility [16].
It is unclear if binding of ssRNAs to Dicer would occur
in vivo, and, if so, what the biological relevance of such an
interaction would be. One necessary feature of active silencers
is the presence of a 5 0-phosphate on the guide strand [31].
siRNAs possessing a 5 0 end that is impaired for phosphoryla-
tion lack the ability to bind Dicer or induce RNAi [25,31]. The
ability of Dicer to distinguish phosphorylated and non-phos-
phorylated targets may be a mechanism for controlling the
loading of RISC. It may also suggest a pathway by which
ssRNAs can enact RNAi [35,36]. In those cases, only ssRNAs
possessing a 5 0-phosphate, or that are 5 0-phosphorylated upon
entering the cell, act as potent inhibitors. These would be
bound more tightly by Dicer, enhancing their association with
other RISC proteins such as Ago 2, TRBP, and PACT [26,37].
Another possibility is that Dicer binding to ssRNAs protects
them from degradative RNases and thereby improves theirtive ﬁgure showing Dicer–ssRNA binding with ssRNA having a 3 0-OH
ncentration of Dicer binding to ssRNA having a 3 0-biotin or a 3 0-OH.
sRNA–Dicer complexes to their respective unbound RNA at each
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evidence also points to the possible involvement of Dicer or
Drosha in the processing of single-stranded RNA substrates
into PIWI-interacting RNAs (piRNAs) [38,39], though this is
still up for debate [40].
Both the RNA binding domains of Dicer, the PAZ domain
and the dsRBD, are involved in the binding of siRNAs and
longer dsRNAs with overhangs [10]. The PAZ domain binds
to the overhangs and positions the dsRBD and concomi-
tantly the RNaseIII domains [23,25]. It has been reported
that the dsRBD can only bind dsRNAs [41,42]. This suggests
that ssRNA complex formation with Dicer is mediated at
least in part by the PAZ domain. 5 0-Phosphate dependence
of the 21-nt ssRNAs for binding with Dicer shown in this
research is identical to the binding behavior of the 5-nt
ssRNAs to the Ago2 PAZ domain [20]. Though we cannot
currently rule out other interactions, our studies strongly
indicate the involvement of the Dicer PAZ domain in bind-
ing ssRNAs.
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